Breast Cancer: Later Stage Treatment
Breast Cancer: Later Stage Treatment
Treatment for advanced breast cancer can vary greatly depending on the specific features of the disease. Here, you'll find important information about those features and treatment options.
To help you understand your diagnosis and treatment options, check out our simple guides:
- A basic guide to living with metastatic breast cancer
- Living with HER2+ breast cancer
- Living with HR+ breast cancer
Later Stage Treatment: Understanding The Options
To help you understand your diagnosis and treatment options, check out our simple guides:
- A basic guide to living with metastatic breast cancer
- Living with HER2+ breast cancer
- Living with HR+ breast cancer
Later Stage Treatment: The Latest Developments
- Experts say HER2- metastatic breast cancer patients should go back to their doctors to see whether their cancer is actually HER2 Low
- Some women previously classified as HER2- may now qualify for treatment with a new drug called Enhertu that can extend overall survival rates
HER2- & HER2 Low: A Change in Treatment Paradigm
- Experts say HER2- metastatic breast cancer patients should go back to their doctors to see whether their cancer is actually HER2 Low
- Some women previously classified as HER2- may now qualify for treatment with a new drug called Enhertu that can extend overall survival rates
How is HER2-Positive Breast Cancer Treated?
Women who are diagnosed with HER2-positive breast cancer have high levels of the HER2 protein on the outside of their cancer cells. For patients with early-stage disease, meaning they have relatively small tumors and no lymph involvement, a number of HER2-directed therapies have dramatically changed the landscape. Thes... Read More
Later Stage Treatment: Hormone Receptor Positive Breast Cancer
Later Stage Treatment: Triple Negative Breast Cancer
The Promise of Immunotherapy
Judy Perkins is a name that will be in the medical text books. She is the first person to be declared free of metastatic breast cancer after a course of immunotherapy. That's a big deal. She is what's known in the world of clinical trials as an "exceptional responder." SurvivorNet went to meet Judy about a year ago at... Read More